CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
President and CEO Richard Scott Struthers sold $5.3M of Crinetics Pharmaceuticals, Inc.
Sold$5,307,931
$49.40Price
107,448Shares
−8%Stake
What CRNX did after the filing
- The stock from Fri, May 10 close, $48.00
- −6.5%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Jun 25 close.
Traded Wed, May 8. Filed Fri, May 10, 12:57 PM ET, during the session. Returns use the May 10 close and the Jun 25 close. Not investment advice.